Skip to main content


Fig. 4 | Diabetology & Metabolic Syndrome

Fig. 4

From: Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome

Fig. 4

Images of insulin receptor type I (IR1), Mas receptor (MasR), nuclear factor kappa B (NF-kB) and pAKT protein quantification by Western blotting in the liver in the control group (C); diabetic and high fat diet mice (HDC); diabetic and high fat diet mice treated with aliskiren (HDA) (a). Graphic representation of IR1 (b), MasR (c), NF-kB (d) and pAKT (e) protein quantification in C, HDC and HDA groups. *P < 0.05, C × HDC; P < 0.05, HDC × HDA. (n = 4–6 mice per group)

Back to article page